1. Home
  2. ACOG vs TISI Comparison

ACOG vs TISI Comparison

Compare ACOG & TISI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACOG
  • TISI
  • Stock Information
  • Founded
  • ACOG 2000
  • TISI 1973
  • Country
  • ACOG Canada
  • TISI United States
  • Employees
  • ACOG N/A
  • TISI N/A
  • Industry
  • ACOG
  • TISI Other Consumer Services
  • Sector
  • ACOG
  • TISI Consumer Discretionary
  • Exchange
  • ACOG Nasdaq
  • TISI Nasdaq
  • Market Cap
  • ACOG 80.3M
  • TISI 80.2M
  • IPO Year
  • ACOG N/A
  • TISI N/A
  • Fundamental
  • Price
  • ACOG $10.80
  • TISI $18.02
  • Analyst Decision
  • ACOG Strong Buy
  • TISI
  • Analyst Count
  • ACOG 1
  • TISI 0
  • Target Price
  • ACOG $20.00
  • TISI N/A
  • AVG Volume (30 Days)
  • ACOG 67.4K
  • TISI 14.8K
  • Earning Date
  • ACOG 08-14-2025
  • TISI 08-07-2025
  • Dividend Yield
  • ACOG N/A
  • TISI N/A
  • EPS Growth
  • ACOG N/A
  • TISI N/A
  • EPS
  • ACOG N/A
  • TISI N/A
  • Revenue
  • ACOG $2,928,654.00
  • TISI $851,327,000.00
  • Revenue This Year
  • ACOG N/A
  • TISI N/A
  • Revenue Next Year
  • ACOG N/A
  • TISI N/A
  • P/E Ratio
  • ACOG N/A
  • TISI N/A
  • Revenue Growth
  • ACOG N/A
  • TISI N/A
  • 52 Week Low
  • ACOG $3.75
  • TISI $8.15
  • 52 Week High
  • ACOG $11.54
  • TISI $26.77
  • Technical
  • Relative Strength Index (RSI)
  • ACOG N/A
  • TISI 39.69
  • Support Level
  • ACOG N/A
  • TISI $18.20
  • Resistance Level
  • ACOG N/A
  • TISI $19.28
  • Average True Range (ATR)
  • ACOG 0.00
  • TISI 1.06
  • MACD
  • ACOG 0.00
  • TISI -0.02
  • Stochastic Oscillator
  • ACOG 0.00
  • TISI 13.80

About ACOG Alpha Cognition Inc. Common Stock

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

About TISI Team Inc.

Team Inc provides specialty industrial services, including inspection, engineering assessment, and mechanical repair and remediation required in maintaining high-temperature and high-pressure piping systems and vessels utilized in refining, petrochemicals, and others. The company operates in two segments, Inspection and Heat Treating and Mechanical Services. The Inspection and Heat Treating segment, which generates maximum revenue, provides conventional and non-destructive testing services for the process, pipeline, and power sectors, pipeline integrity management services, and field heat treating services, as well as associated engineering and condition assessment services. Geographically, the company derives its key revenue from the United States, followed by other countries, and Canada.

Share on Social Networks: